Get started
Author

Yunfeng Shu

Observed name: Yun-feng Shu
ORCID: 0000-0002-2999-2715
Observed ORCID: 0000-0002-2999-2715
OpenAlex ID: A5060588371
Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis
2020 · Jiating Liu, Yunfeng Shu, et al. · Journal of Global Antimicrobial Resistance · 159
PDF
Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis
2021 · Yang Du, Biao Du, et al. · Asian Journal of Psychiatry · 25
Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis
2023 · Wenqiang Kong, Ting Deng, et al. · BMC Infectious Diseases · 19
PDF
Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
2023 · Wenqiang Kong, Xueting Yang, et al. · Frontiers in Public Health · 11
PDF
Calcitonin gene-related peptide receptor antagonist ubrogepant for the treatment of acute migraine: A meta-analysis
2021 · Zizhen Zhang, Yunfeng Shu, et al. · Medicine · 9
Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis
2025 · Wen-qiang Kong, Yun-feng Shu, et al. · BMC Infectious Diseases · 4
PDF
Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
2024 · Wenqiang Kong, Yunfeng Shu, et al. · Expert Opinion on Drug Safety · 1
Works count: 7
Citation count: 227
H-index: 5
I10-index: 4
Year
Topic
Type